689564 event 1775661380 1775661484 With over 25 years of experience in pharmaceutical, biotechnology, and medical device development, Barbara Solow is a recognized leader in non-dilutive funding strategy and healthcare innovation. As the founder of Concept to Market LLC, she has guided organizations ranging from startups to global contractors through product commercialization, regulatory strategy, and public-sector funding, leading programs valued at over $1 billion for U.S. government agencies and helping clients secure more than $3 billion in non-dilutive funding. In this session, Barbara will share how non-dilutive funding can be used to help start and grow a biotech company while minimizing the need for dilutive capital.

]]> Biolocity is a multi-institutional program at Emory University and Georgia Tech that provides education, funding, and commercialization support to early-stage biomedical technologies. 
 

]]> Alyssa Tudor

]]> https://gatech.zoom.us/webinar/register/WN_u7pmRyolQGWu71d8x5YASA 1182 1795